SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DaiS who wrote (9241)6/5/1998 5:45:00 PM
From: Frostman  Read Replies (3) of 23519
 
DiaS, Great post on the Fulgham study! I wonder what the results would have been had they challenged the entire population to 1000ug Muse as the initial intervention? Also, in step 3, I am lost to understand why they elected to not test the remaining 60 subjects in the 500ug failure condition (52% of the total population) to 1000ug Muse. Your 48% figure clearly defines their probable results.

At some point, I would be interested in seeing what you would design as a fair head-to-head test between the four or five ED drugs.

Frostman
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News